aspirin has been researched along with vitamin k semiquinone radical in 218 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (14.22) | 18.7374 |
| 1990's | 21 (9.63) | 18.2507 |
| 2000's | 48 (22.02) | 29.6817 |
| 2010's | 103 (47.25) | 24.3611 |
| 2020's | 15 (6.88) | 2.80 |
| Authors | Studies |
|---|---|
| Esnouf, MP; Green, MR; Hill, HA; Walter, SJ | 1 |
| O'Reilly, RA | 2 |
| Feinstein, PA; Habermann, ET | 1 |
| Lavrinovich, TS; Petukhova, LI; Slutskiĭ, LI | 1 |
| Ben Ismail, M; Ghariani, M; Jais, JM | 1 |
| Goldsweig, HG; Kapusta, M; Schwartz, J | 1 |
| Albo, C; Castaigne, A; Perchet, H; Pham, I; Saal, JP; Verschuren, P | 1 |
| Berbis, P; Bonerandi, JJ; Hesse, S; Juhan-Vague, I; Privat, Y | 1 |
| Brechenmacher, C; Chauvin, M; Koenig, A | 1 |
| Leizorovicz, A; Simonneau, G | 1 |
| Fouchard, J; Guérin, F; Le, F; Py, A | 1 |
| Brechenmacher, C; Chauvin, M; Koenig, A; Théolade, R | 1 |
| Cornu, P | 1 |
| Broeng, L; Jørgensen, PS; Tørholm, C | 1 |
| Delahaye, JP; Sagnol, P | 1 |
| Ollivier, JP | 1 |
| Bourgondiën, FG; Hobbelen, PM; Meuleman, DG; Vogel, GM | 1 |
| Asti, D; Canciani, MT; Cattaneo, M; D'Angelo, A; Mannucci, PM; Tripodi, A; Viganò-D'Angelo, S | 1 |
| Delahaye, JP; Ffrench, P; Malquarti, V; Milon, H; Philippe-Bert, J; Saradarian, W | 1 |
| Quick, AJ | 1 |
| Chang, YH; Wiseman, EH | 1 |
| Chappuis, J; Godquin, B; Guillou, N; Leblanc, J | 1 |
| Carli, H; Gambert, B; Klepping, C; Villand, J | 1 |
| Bolewski, K; Nalewajko, H | 1 |
| Guimbretière, J; Touchard, P | 1 |
| Naess, K | 1 |
| Guillory, JK; Hwang, SC; Lach, JL | 1 |
| Chapuis, Y | 1 |
| Hodara, M; Samama, M | 1 |
| Limonova, SG; Makatsariia, AD | 1 |
| Bergal, S; Denormandie, P; Labaye, A; Nores, JM | 1 |
| Mas, JL | 1 |
| Meier, B | 1 |
| Chalon, S; Lechat, P | 1 |
| Lechat, P | 1 |
| Palatnick, W; Tenenbein, M | 1 |
| Boehlen, F; De Moerloose, P | 1 |
| Cairns, JA; Easton, JD; Hart, RG; Sherman, DG | 1 |
| Schramm, W; Spannagl, M | 1 |
| Boneu, B; Bossavy, JP; Cadroy, Y; Sakariassen, KS; Thalamas, C | 1 |
| Halperin, JL; Hart, RG | 1 |
| Cerbone, AM; Di Minno, G; Tufano, A | 1 |
| Haulon, S; Jude, B; Koussa, M; Susen, S | 1 |
| Dörffler-Melly, J; Mahler, F; Schmidli, J | 1 |
| BEAUMONT, JL; WILLIE, A | 1 |
| KELCHNER, CH | 1 |
| BURGER, M; SEIDEL, K | 1 |
| SOLLOD, AJ | 1 |
| ABBOUD, MA | 1 |
| ETTELDORF, JN; SUMMITT, RL | 1 |
| BORCHARDT, PR; MANNHEIM, JH; METTENLEITER, MW | 1 |
| HAWK, BO; KNIGHT, WA; THOMA, GE | 1 |
| Finsterer, J; Stöllberger, C | 1 |
| Anderson, DR; Bates, SM; Desjardins, L; Douketis, J; Kahn, SR; Kearon, C; Kovacs, MJ; Rodger, M; Solymoss, S; Turpie, AG; Wells, PS | 1 |
| Ezekowitz, MD | 1 |
| Bergqvist, D; Colwell, CW; Geerts, WH; Heit, JA; Lassen, MR; Pineo, GF; Ray, JG | 1 |
| Al-Ahmad, A; Bussey, HI; Horstkotte, D; Miller, N; Pauker, SG; Salem, DN; Stein, PD | 1 |
| Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R | 1 |
| Chesebro, JH; Grill, DE; Hassinger, NL; McBane, RD | 1 |
| Chelly, JE; Despotis, GJ; Hantler, C; Sinha, R | 1 |
| Hunt, BJ; Khamashta, MA | 1 |
| Berthold, HK; Müller-Oerlinghausen, B; Tiaden, JD; Wenzel, E | 1 |
| Husted, SE; Kher, A; Ziegler, BK | 1 |
| Andersen, G; Boysen, G; Husted, SE; Johnsen, SP; Petersen, P | 1 |
| Almange, C; De Place, C; Laurent, M; Leguerrier, A; Lelong, B; Lenormand, C; Leurent, G; Matali, P; Verhoye, JP | 1 |
| Steinbeck, G | 1 |
| Blumenstein, M; Brömsen, J; Schmidt, M | 1 |
| Descarries, LM; Khairy, P; Leduc, L; Mercier, LA | 1 |
| Di Pasquale, G; Rubboli, A | 1 |
| Cattaneo, M | 1 |
| Levi, M | 1 |
| Ezekowitz, M; Lee, R; Nagarakanti, R; Sodhi, S | 1 |
| Boos, CJ; Lip, GY | 1 |
| Bredie, SH; Janssen, MC; Loualidi, A | 1 |
| Ansell, J; Becker, RC; Berger, PB; Douketis, JD; Dunn, AS; Jaffer, AK; Spyropoulos, AC | 1 |
| Albers, GW; Dalen, JE; Fang, MC; Go, AS; Halperin, JL; Lip, GYH; Manning, WJ; Singer, DE | 1 |
| Madias, C; O'Gara, PT; Pauker, SG; Salem, DN | 1 |
| Bates, SM; Greer, IA; Hirsh, J; Pabinger, I; Sofaer, S | 1 |
| Chalmers, E; Chan, A; deVeber, G; Kirkham, F; Massicotte, P; Michelson, AD; Monagle, P | 1 |
| Goldstein, L; Marmagkiolis, K; Nikolaidis, IG; Politis, T | 1 |
| Bode, Ch; Schwarz, M | 1 |
| Delaunay, O; Doucet, J; Gréboval-Furstenfeld, E; M'bello, L; Moirot, P; Mouton-Schleifer, D; Pesqué, T; Tavildari, A | 1 |
| Estivin, S; Gentric, A; Jestin, C | 1 |
| de Boer, A; Klungel, OH; Schalekamp, T; Souverein, PC | 1 |
| Chrolavicius, S; Connolly, SJ; Hart, RG; Hohnloser, SH; Pfeffer, M; Pogue, J; Yusuf, S | 1 |
| Go, AS | 1 |
| Bergmann, C; Krpciar, V; Rose, E; Vetter, S; Volkmann, H; Walter, M | 1 |
| Brown, GA | 1 |
| Crijns, HJ; Dinh, T; Pisters, R | 1 |
| Butaffuoco, F; Richard, T; Vanhaeverbeek, M | 1 |
| Goldstein, LB | 1 |
| Diener, HC; Weber, R; Weimar, C | 1 |
| Apostolakis, S; Lane, DA; Lip, GY; Shantsila, E | 1 |
| Grove, EL; Storey, RF | 1 |
| Abildstrom, SZ; Andersson, C; Gislason, GH; Hansen, ML; Hansen, PR; Hvelplund, A; Jørgensen, C; Køber, L; Madsen, JK; Sørensen, R; Torp-Pedersen, C | 1 |
| Lindhoff-Last, E; Tacke, J | 1 |
| Büller, HR; Ettema, HB; Struijk-Mulder, MC; Verheyen, CC | 1 |
| Eikelboom, JW; Hirsh, J; Sobieraj-Teague, M | 1 |
| Brennan, MT; Furney, SL; Hong, CH; Lockhart, PB; Napeñas, JJ | 1 |
| Eerenberg, E; Kamphuisen, PW; Levi, MM; Löwenberg, E | 1 |
| Connolly, SJ; Diaz, R; Eikelboom, JW; Flaker, G; Hart, R; Hohnloser, S; Joyner, C; Lawrence, J; O'Donnell, M; Pais, P; Pogue, J; Synhorst, D; Yusuf, S | 1 |
| Chen, FY; Cohn, LH; DiBardino, DJ; ElBardissi, AW; Yamashita, MH | 1 |
| Bouillet, L; Chiquet, C; Kouprianoff, S; Romanet, JP | 1 |
| Budaj, A; Chrolavicius, S; Connolly, SJ; De Caterina, R; Morais, J; Pogue, J; Renda, G; Yusuf, S | 1 |
| Cámara, ML; Colli, A; D'Amico, R; Mestres, CA; Mulet, J; Pomar, JL; Ruyra, X | 1 |
| Schlitt, A | 1 |
| Hillege, HL; van der Meer, J; Veeger, NJ; Zijlstra, F | 1 |
| Hiratzka, LF | 1 |
| HIGLEY, CS | 1 |
| Corrao, S; Iorio, A; Mannucci, PM; Marcucci, M; Marengoni, A; Nobili, A; Pasina, L; Salerno, F; Tettamanti, M | 1 |
| Alvarez-Contreras, L; Brugaletta, S; Cola, C; de Antonio, M; Ferreira-González, I; García-Picart, J; Martí, V; Martin-Yuste, V; Sabaté, M | 1 |
| Allison, PM; Bayat, M; Bracey, AW; Chen, AJ; Reyes, MA | 1 |
| Barroeta-Espar, I; Delgado-Mederos, R; Martí-Fàbregas, J; Mateo, J; Sáinz Pelayo, MP; Vidal-Jordana, A | 1 |
| Ahmad, M; Fatima, N; Imran, H; Rahman, A; Rehman, Z; Sohail, T; Yaqeen, Z | 1 |
| De Caterina, R; Hylek, EM | 1 |
| Hobbs, FD; Leach, I | 1 |
| Ahlehoff, O; Gislason, GH; Hansen, ML; Hansen, PR; Lane, DA; Lindhardsen, J; Lip, GY; Olesen, JB; Raunsø, J; Tolstrup, JS; Torp-Pedersen, C | 1 |
| Connolly, SJ; de Caterina, R; Eikelboom, JW; Hart, RG; Hirsh, J; Hohnloser, S; Ng, J; Pogue, J; Yusuf, S | 1 |
| Fehri, W; Filali, T; Gommidh, M; Haggui, A; Hajlaoui, N; Haouala, H; Jdaida, B; Lahidheb, D; Saaidi, I | 1 |
| Douketis, JD; Dunn, AS; Eckman, MH; Jaffer, AK; Kunz, R; Mayr, M; Spencer, FA; Spyropoulos, AC | 1 |
| Eckman, MH; Fang, MC; Go, AS; Halperin, JL; Howard, PA; Hughes, M; Hylek, EM; Lane, DA; Lip, GYH; Manning, WJ; Schulman, S; Singer, DE; Spencer, FA; You, JJ | 1 |
| Fremes, SE; Rubens, FD; Sun, JC; Teoh, KH; Whitlock, RP | 1 |
| Abt, Rde B; Botelho, FN; Carvalho, RS; Cirenza, C; Gianotto, M; Luize, CM; Mallmann, FB; Nogueira, FL; Oliveira, LH; Paola, AA; Paul, LC; Silva, NJ | 1 |
| Krittalak, K; Sawanyawisuth, K; Tiamkao, S | 1 |
| Ageno, W; Agnelli, G; Becattini, C; Bianchi, M; Bucherini, E; Eichinger, S; Grandone, E; Moia, M; Prandoni, P; Schenone, A; Silingardi, M; Vandelli, MR | 1 |
| De Smet, PA; Kramers, C; Lamfers, EJ; Pop, GA; Roukens, M; Warlé-Van Herwaarden, MF | 1 |
| Callahan, S; Goldsberry, A; Kim, G; Yoo, S | 1 |
| Fischer, AM; Frank, M | 1 |
| Gislason, GH; Hansen, CM; Hansen, ML; Karasoy, D; Kristensen, SL; Køber, L; Lamberts, M; Olesen, JB; Ruwald, MH; Torp-Pedersen, C | 1 |
| Budaj, A; Connolly, SJ; Eikelboom, JW; Flaker, GC; Hart, RG; Husted, S; Kaatz, S; Lip, GY; Shestakovska, O; Yusuf, S | 1 |
| Bergert, H; Bötticher, G; Gäbel, G; Saeger, HD; Weiss, N | 1 |
| Yano, T; Yokoyama, A | 1 |
| Bejan-Angoulvant, T; Jonville-Béra, AP | 1 |
| Lip, GY | 1 |
| Kastrati, A; Martischnig, A; Mayer, K; Mehilli, J; Sarafoff, N; Sibbing, D; Wealer, J | 1 |
| Apostolakis, S; Lip, GY; Shantsila, E | 1 |
| Cameron, C; Carrier, M; Castellucci, LA; Clifford, T; Coyle, D; Gandara, E; Le Gal, G; Rodger, MA; Wells, G; Wells, PS | 1 |
| Fiaccadori, E; Maggiore, U; Regolisti, G | 1 |
| Diez-Ewald, M | 1 |
| Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Lassen, JF; Lip, GY; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C | 1 |
| Airaksinen, KE; Biancari, F; Karjalainen, PP; Kirchhof, P; Kiviniemi, T; Laine, M; Lip, GY; Niemelä, M; Rubboli, A; Schlitt, A; Valencia, J; Vikman, S | 1 |
| Baur, LH; Cheriex, EC; Crijns, HJ; Dinh, T; Heesen, WF; Kamp, O; Lindeboom, JE; Pisters, R; Prins, MH; Smeets, JL; Tieleman, RG; Verheugt, FW | 1 |
| Dorian, P; Hernandez, L; Iloeje, U; Kongnakorn, T; Kuznik, A; Lanitis, T; Lip, GY; Liu, LZ; Phatak, H; Rublee, DA | 1 |
| Connolly, SJ; Coppens, M; Eikelboom, JW; Shestakovska, O; Synhorst, D; Yusuf, S | 1 |
| Gislason, G; Sørensen, R | 1 |
| Piątek, B; Piwnik, M; Podgórski, M; Strzelczyk, J | 1 |
| Thompson, PL; Verheugt, FW | 1 |
| Adriaenssens, T; Dewilde, WJ; Hansen, ML; Janssen, PW; Lamberts, M; Storey, RF; Ten Berg, JM; Verheugt, FW | 2 |
| Capodanno, D; Lip, GY | 1 |
| Jarmak, A; Jończyk-Skórka, K; Kowalski, J; Śliwczyńska-Rodziewicz, D | 1 |
| Bellesme, C; Cabasson, S; Deiva, K; Ducreux, D; Husson, B; Saliou, G; Simonnet, H; Tardieu, M; Théaudin, M; Toulgoat, F | 1 |
| Ahrens-Nicklas, RC; Edmondson, AC; Ficicioglu, C | 1 |
| Saliba, W | 1 |
| Blann, AD; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F | 1 |
| Calò, PG; Erdas, E; Furcas, S; Medas, F; Nicolosi, A; Pisano, G; Podda, F | 1 |
| Gaist, D; García Rodríguez, LA; Hallas, J; Pottegård, A; Poulsen, FR | 1 |
| Bartels, DB; Diener, HC; Dubner, SJ; Elsaesser, A; Halperin, JL; Huisman, MV; Lip, GY; Ma, C; Paquette, M; Rothman, KJ; Teutsch, C; Zint, K | 1 |
| Bouziana, SD; Dourliou, V; Giampatzis, V; Hatzitolios, AI; Kostaki, S; Papadopoulou, M; Savopoulos, C; Sofogianni, A; Spanou, M; Tziomalos, K | 1 |
| Cao, J; Cui, X; Han, Z; Song, W; Wen, H; Xu, Y | 1 |
| Cavallazzi, R; Marik, PE | 1 |
| Ajjan, RA; Angiolillo, DJ; Bass, TA; Bhatti, M; Cho, JR; DeGroat, C; Franchi, F; Guzman, LA; King, R; Phoenix, F; Rollini, F; Tello-Montoliu, A; Zenni, MM | 1 |
| Carrier, M; Gándara, E; Gonzalez, JP; LeGal, G; Vazquez, FJ | 1 |
| Kozuki, T | 1 |
| Holzmann, D; Kindler, R; Soyka, MB; Stadler, RR | 1 |
| Chalayer, E; Chapelle, C; Elalamy, I; Laporte, S; Leleu, X; Tardy, B | 1 |
| Bauters, C; Ducrocq, G; Lamblin, N; Lemesle, G; Schurtz, G | 1 |
| Bordignon, S; Chun, JK; Dugo, D; Fürnkranz, A; Konstantinou, A; Perrotta, L; Schmidt, B | 1 |
| Benedetti, R; Fenoglio, L; Imberti, D; Pomero, F | 1 |
| Handin, RI | 1 |
| Brandl, R; Braun, D; Braun, S; Chandraratne, S; Eckart, A; Hoppe, B; Jamasbi, J; Kolb, C; Konrad, I; Lennerz, C; Lorenz, M; Massberg, S; Petzold, T; Regenauer, R; Schubert, I; Schulz, C; Siess, W; Thienel, M | 1 |
| Ambrosi, P; Daumas, A; Giorgi, R; Villani, P | 1 |
| Bos, J; Burden, AM; de Boer, A; de Vries, F; Gieling, EM; Kramers, C; van den Ham, HA; van Onzenoort, H | 1 |
| Gaist, D; García Rodríguez, LA; Hallas, J; Halle, B; Hellfritzsch, M; Pottegård, A; Poulsen, FR | 1 |
| Burden, AM; de Boer, A; de Vries, F; Ebbelaar, C; Schalekamp, T; Souverein, P; Stolk, LM; Ten Cate-Hoek, A | 1 |
| Belmin, J; Jarzebowski, W; Lafuente-Lafuente, C; Melkonian, M; Pautas, E; Siguret, V | 1 |
| Jolobe, OMP | 1 |
| Aceves-Velázquez, E; Herrera-Alarcón, V; Rodríguez-Chávez, L; Vieyra-Herrera, G | 1 |
| Haefeli, WE; Mächler, S; Meid, AD; Mikus, G | 1 |
| Blank, BF; Calvert, M; Camm, AJ; Chlouverakis, G; Diener, HC; Goette, A; Huening, A; Kirchhof, P; Lip, GYH; Simantirakis, E; Vardas, P | 1 |
| Berger, JS; Bjerring Olesen, J; Gerds, TA; Gislason, GH; Hansen, ML; Lamberts, M; Langtved Pallisgaard, J; Nissen Bonde, A; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C | 1 |
| Becher, PM; Blankenberg, S; Fluschnik, N; Schnabel, R; Westermann, D | 1 |
| Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N | 1 |
| Campbell, HE; Dumonceau, JM; Fujishiro, M; Gralnek, IM; Hunt, RH; Lanas, A; Rostom, A; Scheiman, JM; Sung, JJY; Villanueva, C | 1 |
| Heuts, S; Huisman, MV; Jansen, EK; Klautz, RJM; Klok, FA; Olsthoorn, JR; Sardari Nia, P; Tomsic, A; van der Wall, SJ; Vonk, ABA | 1 |
| Baumann Kreuziger, L; Karkouti, K; Massicotte, MP; Tweddell, J | 1 |
| Ben-Dor, I; Buchanan, KD; Gajanana, D; Iantorno, M; Okubagzi, PG; Pichard, AD; Rogers, T; Satler, LF; Thourani, VH; Torguson, R; Waksman, R; Weintraub, WS | 1 |
| Undas, A; Zabczyk, M | 1 |
| Grau, A; Haeusler, KG; Heuschmann, PU; Krogias, C; Veltkamp, R; Wutzler, A | 1 |
| Alexander, JH; Aronson, R; Averkov, O; Bahit, MC; Berwanger, O; Budaj, A; Darius, H; Goodman, SG; Granger, CB; Heizer, G; Hijazi, Z; Li, J; Lopes, RD; Massaro, T; Mehran, R; Parkhomenko, A; Sinnaeve, P; Storey, RF; Thiele, H; Vinereanu, D; Vora, AN; Windecker, S | 1 |
| Bertoletti, L; Cucherat, M; Grange, C; Jardel, S; Lega, JC; Mai, V; Provencher, S | 1 |
| Green, JB; Guimarães, PO; Holman, RR; Lokhnygina, Y; Lopes, RD; McGuire, DK; Peterson, ED; Stevens, SR | 1 |
| Chen, S; Gao, X; Ge, Z; Kong, X; Wang, F; Wang, Z; Zhang, J; Zuo, G | 1 |
| Imberti, D; Mastroiacovo, D; Pomero, F | 1 |
| Alexander, JH; Aronson, R; Averkov, O; Budaj, A; Darius, H; Goodman, SG; Granger, CB; Guimaraes, PO; Kobalava, Z; Kong, DF; Lopes, RD; Mehran, R; Mehta, RH; Mirza, Z; Parkhomenko, A; Quadros, A; Thiele, H; Vora, AN; Windecker, S; Wojdyla, DM | 1 |
| Alexander, JH; Aronson, R; Aschermann, M; Brieger, D; Cura, F; Darius, H; de Waha-Thiele, S; Engstrøm, T; Fridrich, V; Goodman, SG; Granger, CB; Halvorsen, S; Heizer, G; Huber, K; Jones, WS; Jones-Burton, C; Kang, HJ; Leiva-Pons, JL; Lewis, BS; Lopes, RD; Malaga, G; Massaro, T; Mehran, R; Meneveau, N; Merkely, B; Milicic, D; Morais, J; Potpara, TS; Raev, D; Sabaté, M; Welsh, RC; Windecker, S; Xavier, D | 1 |
| Burden, A; de Boer, A; de Vries, F; Gieling, E; Kramers, C; Ten Cate, V; van Onzenoort, HAW; Williams, R | 1 |
| Alexander, JH; Aronson, R; Goodman, SG; Granger, CB; Leonardi, S; Lopes, RD; Mehran, R; Storey, RF; Thiele, H; Thomas, L; Valgimigli, M; Vinereanu, D; Vora, AN; Windecker, S; Wojdyla, DM | 1 |
| Bungard, TJ; Butcher, K; Hodgson, M; Schultz, K; Wan, A | 1 |
| Chouliaras, C; Kouraklis, G; Liagkos, G; Spyropoulos, C; Tsourouflis, G; Vagianos, CE | 1 |
| Alexopoulos, D; Benetou, DR; Mpahara, A; Varlamos, C | 1 |
| Duarte-García, A; Knight, JS; Madison, JA; Zuo, Y | 1 |
| Alexander, JH; Aronson, R; Goodman, SG; Granger, CB; Lopes, RD; Mehran, R; Thomas, L; Vora, AN; Windecker, S; Wojdyla, D | 1 |
| Andreoli, L; Chighizola, CB; Meroni, PL; Sciascia, S | 1 |
| Darius, H | 1 |
| Alexander, JH; Aronson, R; Bahit, MC; Berwanger, O; Darius, H; de Waha-Thiele, S; Granger, CB; Halvorsen, S; Hijazi, Z; Li, Z; Lopes, RD; Mehran, R; Parkhomenko, A; Sinnaeve, P; Storey, RF; Windecker, S; Wojdyla, DM | 1 |
| Wang, Q; Yang, K | 1 |
| Adlbrecht, C; Cuhaj, C; Delle-Karth, G; Grabenwöger, M; Hasan, W; Mach, M; Poschner, T; Strouhal, A; Szalkiewicz, P; Watzal, V; Winkler, B | 1 |
| Achini, F; Albisetti, M; Brotschi, B; Crameri, O; Rizzi, M | 1 |
| Alexander, JH; Aronson, R; Dehghani, P; Goodman, S; Granger, CB; Halvorsen, S; Lopes, R; Mehran, R; Parkhomenko, A; Vinereanu, D; Vora, AN; Welsh, RC; Windecker, S; Wojdyla, DM | 1 |
| de Borst, GJ; Hannink, G; Kramers, K; Maas, DPMSM; Mees, BME; Reijnen, MMPJ; Riksen, NP; Ten Cate, H; van der Vijver-Coppen, RJ; Warlé, MC; Willems, LH; Zeebregts, CJ | 1 |
| Depreitere, B; Laic, RAG; Vander Sloten, J; Verhamme, P | 1 |
70 review(s) available for aspirin and vitamin k semiquinone radical
| Article | Year |
|---|---|
Vitamin K and the oral anticoagulant drugs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anticoagulants; Aspirin; Barbiturates; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Chemical Phenomena; Chemistry; Cholestyramine Resin; Disulfiram; Diuretics; Drug Interactions; Ethanol; Female; Humans; Infant, Newborn; Male; Phenylbutazone; Prothrombin; Receptors, Drug; Vitamin K; Warfarin | 1976 |
[Klinefelter's syndrome and leg ulcers: role of blood coagulation disorders].
Topics: Adult; Aspirin; Blood Coagulation Disorders; Gonadal Steroid Hormones; Humans; Klinefelter Syndrome; Leg Ulcer; Male; Platelet Aggregation; Vitamin K | 1992 |
[Comparison of various methods of prevention of venous thrombosis in orthopedics].
Topics: Aspirin; Dextrans; Heparin; Hip Prosthesis; Humans; Knee Prosthesis; Meta-Analysis as Topic; Odds Ratio; Orthopedics; Risk Factors; Thromboembolism; Vitamin K | 1992 |
[Isolated atrial fibrillation. The risk of embolism and its prevention].
Topics: 4-Hydroxycoumarins; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Humans; Indenes; Intracranial Embolism and Thrombosis; Male; Middle Aged; Recurrence; Risk Factors; Vitamin K; Warfarin | 1992 |
[Embolic complications of chronic atrial fibrillation].
Topics: Aspirin; Atrial Fibrillation; Chronic Disease; Heart Valve Diseases; Humans; Primary Prevention; Prognosis; Recurrence; Risk; Thromboembolism; Vitamin K | 1992 |
[Prevention of venous thrombosis in surgery].
Topics: Aspirin; Blood Coagulation Tests; Dextrans; Heparin, Low-Molecular-Weight; Humans; Intraoperative Care; Postoperative Care; Thromboembolism; Vitamin K | 1990 |
[Prevention of postoperative venous thrombosis and pulmonary embolism. Consensus conference 8 March 1991 by Assistance Publique-Hopitaux de Paris].
Topics: Anesthesia; Aspirin; Bandages; Dextrans; Female; France; Heparin, Low-Molecular-Weight; Humans; Male; Postoperative Complications; Pulmonary Embolism; Thrombosis; Vitamin K | 1991 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
Warfarin metabolism and drug-drug interactions.
Topics: Anti-Bacterial Agents; Aspirin; Barbiturates; Cholestyramine Resin; Clofibrate; Diuretics; Drug Interactions; Ethanol; Humans; Rifampin; Vitamin K; Warfarin | 1987 |
[Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications].
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Heart Valve Prosthesis; Hemorrhage; Humans; Thromboembolism; Vitamin K | 1985 |
Hemostasis in surgical procedures.
Topics: Acetylcholine; Antimetabolites; Aspirin; Autonomic Nervous System; Blood Circulation; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Calcium; Cell Aggregation; Clot Retraction; Dicumarol; Epinephrine; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Fibrin; Fibrinogen; Hemorrhage; Hemostasis; Humans; Prothrombin; Prothrombin Time; Surgical Procedures, Operative; Thrombin; Vasoconstrictor Agents; Vasodilator Agents; Vitamin K | 1969 |
[Anticoagulants and pregnancy].
Topics: Anticoagulants; Aspirin; Blood Platelets; Coumarins; Disseminated Intravascular Coagulation; Female; Hemostasis; Heparin; Humans; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Risk; Thromboembolism; Vitamin K | 1981 |
[Prophylaxis of deep vein thrombosis in orthopedic surgery. Discussion and review of the literature].
Topics: 4-Hydroxycoumarins; Anticoagulants; Aspirin; Dextrans; Heparin; Hip Prosthesis; Humans; Indenes; Knee Joint; Knee Prosthesis; Postoperative Complications; Thrombophlebitis; Vitamin K | 1994 |
[Thromboembolic complications in the course of non-valvular atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Echocardiography; Europe; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Placebos; Risk Factors; Thromboembolism; Vitamin K | 1995 |
[Anticoagulation in cardiology].
Topics: 4-Hydroxycoumarins; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Coumarins; Cyclooxygenase Inhibitors; Heparin; Humans; Indenes; Myocardial Infarction; Postoperative Care; Vitamin K | 1995 |
[Antithrombotic therapy of atrial fibrillation].
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Treatment Outcome; Vitamin K; Warfarin | 1996 |
[Anticoagulants and platelet antiaggregants: lessons of the last 20 years].
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Platelet Aggregation Inhibitors; Vitamin K | 1998 |
Prevention of stroke in patients with nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Male; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Vitamin K; Warfarin | 1998 |
Atrial fibrillation and stroke : concepts and controversies.
Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Humans; Intracranial Embolism; Prevalence; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Thrombosis; Vitamin K; Warfarin | 2001 |
Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
Topics: Aged; Angina, Unstable; Anticoagulants; Aspirin; Female; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Lysine; Male; Practice Guidelines as Topic; Secondary Prevention; Thromboembolism; Veins; Vitamin K | 2001 |
[Peripheral arterial revascularization: which antithrombotic agents?].
Topics: 4-Hydroxycoumarins; Anticoagulants; Arteries; Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Indenes; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Vascular Surgical Procedures; Vitamin K | 2001 |
Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Anticoagulants; Aspirin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Assessment; Venous Thrombosis; Vitamin K | 2004 |
Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Aspirin; Bioprosthesis; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; International Normalized Ratio; Postoperative Complications; Prosthesis Design; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Thromboembolism; Vitamin K | 2004 |
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Medicine; Extremities; Fibrinolytic Agents; Heparin; Humans; Intermittent Claudication; Ischemia; Randomized Controlled Trials as Topic; Risk Assessment; Tetrazoles; Thromboembolism; Ticlopidine; Vitamin K | 2004 |
Guidelines and alternatives for neuraxial anesthesia and venous thromboembolism prophylaxis in major orthopedic surgery.
Topics: Anesthesia, Conduction; Anesthesia, General; Aspirin; Factor Xa Inhibitors; Heparin; Humans; Orthopedic Procedures; Venous Thrombosis; Vitamin K; Warfarin | 2004 |
Long-term anticoagulant therapy in patients with coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Coronary Artery Disease; Drug Combinations; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin K | 2006 |
[Prevention of thromboembolism in patients with atrial fibrillation].
Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Clinical Trials as Topic; Echocardiography; Electric Countershock; Fibrinolytic Agents; Heart Diseases; Humans; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stroke; Thromboembolism; Thrombosis; Time Factors; Vitamin K | 2006 |
Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence.
Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Pyridines; Stents; Vitamin K; Warfarin | 2007 |
Haemorrhagic stroke during anti-platelet therapy.
Topics: Acute Coronary Syndrome; Aspirin; Cerebral Hemorrhage; Clinical Trials as Topic; Humans; Intracranial Hemorrhages; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Vitamin K | 2008 |
Chronic antithrombotic therapy in post-myocardial infarction patients.
Topics: Anticoagulants; Aspirin; Azetidines; Benzylamines; Clopidogrel; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Thrombolytic Therapy; Thrombosis; Ticlopidine; Vitamin K; Warfarin | 2008 |
Antithrombotic treatment in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Combinations; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Stroke; Vitamin K; Warfarin | 2008 |
Indications of combined vitamin K antagonists and aspirin therapy.
Topics: Aspirin; Atherosclerosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Vitamin K | 2009 |
Approach to and management of the acute stroke patient with atrial fibrillation: a literature review.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Atrial Fibrillation; Factor VIIa; Heparin; Humans; Intracranial Hemorrhages; Plasma; Recombinant Proteins; Stroke; Thrombolytic Therapy; Vitamin K; Warfarin | 2008 |
[Antithrombotic therapy in atrial fibrillation: when vitamin K antagonists? When aspirin? When heparin? When combinations of anticoagulant and antiplatelet drugs?].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Vitamin K | 2009 |
Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials.
Topics: Anticoagulants; Aspirin; Heparin, Low-Molecular-Weight; Humans; Orthopedic Procedures; Randomized Controlled Trials as Topic; Venous Thromboembolism; Vitamin K | 2009 |
[Medicinal therapy for interventional surgery of the peripheral vascular system].
Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Therapy, Combination; Heparin; Humans; Infusions, Intravenous; Ischemia; Leg; Long-Term Care; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Thrombocytopenia; Thrombosis; Ticlopidine; Vitamin K | 2010 |
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Casts, Surgical; Evidence-Based Medicine; Fibrinolytic Agents; Guideline Adherence; Heparin; Hip Fractures; Humans; Knee; Lower Extremity; Orthopedic Procedures; Postoperative Hemorrhage; Practice Guidelines as Topic; Practice Patterns, Physicians'; Thrombosis; Treatment Outcome; Vitamin K | 2010 |
Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
Topics: Anticoagulants; Antithrombins; Aspirin; Factor Xa Inhibitors; Hemorrhage; Hemostatics; Heparin; Heparin, Low-Molecular-Weight; Humans; Incidence; Platelet Aggregation Inhibitors; Polysaccharides; Risk Factors; Thienopyridines; Vitamin K | 2010 |
[New aspects on "triple therapy" after coronary stent implantation].
Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk Factors; Stents; Stroke; Thrombosis; Ticlopidine; Vitamin K | 2010 |
Stroke prevention in atrial fibrillation: current status and near-future directions.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Aspirin; Atrial Fibrillation; Contraindications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Factor Xa Inhibitors; Fibrinolytic Agents; Guideline Adherence; Humans; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin K | 2011 |
Challenges of stroke prevention in patients with atrial fibrillation in clinical practice.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Monitoring; Humans; Stroke; Vitamin K | 2011 |
The management of antithrombotic medication in skin surgery.
Topics: Anticoagulants; Antithrombins; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Dermatologic Surgical Procedures; Fibrinolytic Agents; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Morpholines; Platelet Aggregation Inhibitors; Polysaccharides; Risk Assessment; Rivaroxaban; Thienopyridines; Thiophenes; Vitamin K; Warfarin | 2012 |
[Prescription and monitoring of anticoagulant therapies].
Topics: 4-Hydroxycoumarins; Anticoagulants; Aspirin; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Indenes; Monitoring, Physiologic; Practice Patterns, Physicians'; Thrombin; Vitamin K | 2012 |
[Antithrombotic therapy after peripheral vascular treatment: what is evidence-based?].
Topics: Aortic Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endarterectomy; Evidence-Based Medicine; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Humans; Iliac Artery; International Normalized Ratio; Peripheral Arterial Disease; Polyethylene Terephthalates; Polytetrafluoroethylene; Popliteal Artery; Postoperative Complications; Prosthesis Design; Ticlopidine; Veins; Vitamin K | 2012 |
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biomarkers; Echocardiography; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Practice Guidelines as Topic; Renal Insufficiency; Risk Assessment; Risk Factors; Stroke; Thromboembolism; Vitamin K | 2013 |
Pharmacokinetic considerations for antithrombotic therapies in stroke.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stroke; Tetrazoles; Thiophenes; Thrombin; Ticlopidine; Vitamin K | 2013 |
Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Topics: Anticoagulants; Aspirin; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pulmonary Embolism; Randomized Controlled Trials as Topic; Secondary Prevention; Venous Thrombosis; Vitamin K; Warfarin | 2013 |
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis.
Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Thiophenes; Venous Thromboembolism; Vitamin K | 2013 |
Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Ticlopidine; Vitamin K; Warfarin | 2014 |
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Ticlopidine; Vitamin K | 2014 |
An 8-year-old girl with abdominal pain and mental status changes.
Topics: Abdominal Pain; Acute Disease; Ankle Injuries; Arthralgia; Aspirin; Child; Consciousness Disorders; Diagnosis, Differential; Fatigue; Female; Hemorrhagic Disorders; Humans; Hyperammonemia; Hypoglycemia; Hypotension; Lactulose; Liver Failure; Reye Syndrome; Rheumatic Fever; Vitamin K | 2015 |
Non-vitamin K antagonist oral anticoagulants: new choices for patient management in atrial fibrillation.
Topics: Age Factors; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Comorbidity; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Risk Factors; Sex Factors; Stroke; Vitamin K | 2015 |
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Humans; Mortality; Numbers Needed To Treat; Observational Studies as Topic; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Stroke; Thiazoles; Thrombophilia; Ticlopidine; Vitamin K | 2015 |
Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Aspirin; Data Collection; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Sex Factors; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2015 |
Risk of major bleeding in patients receiving vitamin K antagonists or low doses of aspirin. A systematic review and meta-analysis.
Topics: Anticoagulants; Aspirin; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Odds Ratio; Risk Assessment; Vitamin K | 2016 |
Skin problems and EGFR-tyrosine kinase inhibitor.
Topics: Administration, Cutaneous; Administration, Oral; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Dermatologic Agents; ErbB Receptors; Exanthema; Humans; Paronychia; Patient Education as Topic; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quality of Life; Randomized Controlled Trials as Topic; Retinoids; Severity of Illness Index; Skin; Skin Diseases; Sunscreening Agents; Vitamin K | 2016 |
Effect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Humans; Outpatients; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Vitamin K | 2016 |
The History of Antithrombotic Therapy: The Discovery of Heparin, the Vitamin K Antagonists, and the Utility of Aspirin.
Topics: Aspirin; Fibrinolytic Agents; Heparin; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Vitamin K | 2016 |
Meta-analysis of major bleeding events on aspirin versus vitamin K antagonists in randomized trials.
Topics: Aspirin; Global Health; Hemorrhage; Humans; Incidence; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Thrombosis; Vitamin K | 2017 |
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2017 |
Non-variceal upper gastrointestinal bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Duodenum; Endoscopy; Esophagus; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Prognosis; Stomach; Upper Gastrointestinal Tract; Vitamin K | 2018 |
Antithrombotic therapy management of adult and pediatric cardiac surgery patients.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Blood Coagulation; Cardiac Surgical Procedures; Cardiology; Child; Coronary Artery Bypass; Drug Administration Schedule; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Diseases; Heart-Assist Devices; Hemorrhage; Hemostasis; Heparin; Humans; Inflammation; Intraoperative Period; Perioperative Period; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Protamines; Risk; Thrombolytic Therapy; Thrombosis; Vitamin K | 2018 |
Antithrombotic medications and their impact on fibrin clot structure and function.
Topics: Anticoagulants; Aspirin; Fibrin; Fibrinolytic Agents; Humans; Purinergic P2Y Receptor Antagonists; Thrombosis; Vitamin K | 2018 |
Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Coagulation; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Male; Network Meta-Analysis; Platelet Aggregation Inhibitors; Secondary Prevention; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin | 2019 |
Clinical Outcomes of Antithrombotic Strategies for Patients with Atrial Fibrillation After Percutaneous Coronary Intervention.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Observational Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Vitamin K | 2019 |
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Dabigatran; Glycosaminoglycans; Hemorrhage; Humans; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk Factors; Rivaroxaban; Treatment Outcome; Venous Thromboembolism; Vitamin K | 2020 |
Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Topics: Aspirin; Atrial Fibrillation; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Vitamin K | 2021 |
Treatment of thrombotic antiphospholipid syndrome in adults and children.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Child; Humans; Prospective Studies; Thrombosis; Vitamin K | 2020 |
Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneo
Topics: 4-Hydroxycoumarins; Aged; Aspirin; Atrial Fibrillation; Diabetes Mellitus; Diabetic Cardiomyopathies; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Indenes; Male; Observational Studies as Topic; Percutaneous Coronary Intervention; Postoperative Complications; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin K | 2021 |
Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.
Topics: Aspirin; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Network Meta-Analysis; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Rivaroxaban; Ticagrelor; Vitamin K | 2022 |
26 trial(s) available for aspirin and vitamin k semiquinone radical
| Article | Year |
|---|---|
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
[Permeability of aortocoronary bypass after 6 months. A multicenter French study].
Topics: Adult; Aged; Aspirin; Coronary Angiography; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Risk Factors; Vitamin K | 1991 |
[Long-term antithrombotic treatment in coronary disease].
Topics: 4-Hydroxycoumarins; Anticoagulants; Aspirin; Clinical Trials as Topic; Coronary Disease; Fibrinolytic Agents; Humans; Indenes; Long-Term Care; Middle Aged; Myocardial Infarction; Platelet Aggregation; Vitamin K | 1983 |
[Study on secondary prevention of myocardial infarct (EPSIM). Work of the EPSIM research group].
Topics: 4-Hydroxycoumarins; Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Female; France; Humans; Indenes; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Statistics as Topic; Vitamin K | 1982 |
[Thromboembolic complications in the course of non-valvular atrial fibrillation].
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Echocardiography; Europe; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Placebos; Risk Factors; Thromboembolism; Vitamin K | 1995 |
Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.
Topics: Adolescent; Adult; Anticoagulants; Aspirin; Collagen; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Male; Phenindione; Thromboplastin; Thrombosis; Vitamin K | 1999 |
Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Atrial Fibrillation; Blood Loss, Surgical; Cohort Studies; Dalteparin; Elective Surgical Procedures; Feasibility Studies; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Intraoperative Complications; Postoperative Complications; Postoperative Hemorrhage; Premedication; Preoperative Care; Prospective Studies; Risk; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2004 |
Which parameters differ in very old patients with chronic atrial fibrillation treated by anticoagulant or aspirin? Antithrombotic treatment of atrial fibrillation in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Risk Factors; Vitamin K | 2008 |
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vascular Diseases; Vitamin K | 2009 |
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Administration Schedule; Fibrinolytic Agents; Hemorrhage; Humans; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Research Design; Retreatment; Stroke; Treatment Failure; Vitamin K; Warfarin | 2010 |
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W.
Topics: Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Irbesartan; Kaplan-Meier Estimate; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vitamin K | 2010 |
Fourteen-year follow-up from CABADAS: vitamin K antagonists or dipyridamole not superior to aspirin.
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Phenprocoumon; Vitamin K | 2010 |
Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sensitivity and Specificity; Stroke; Ticlopidine; Vitamin K | 2011 |
Aspirin for preventing the recurrence of venous thromboembolism.
Topics: Aged; Anticoagulants; Aspirin; Double-Blind Method; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Secondary Prevention; Venous Thromboembolism; Venous Thrombosis; Vitamin K | 2012 |
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Contraindications; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Risk Factors; Stroke; Vitamin K; Warfarin | 2012 |
One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Vessels; Female; Fibrinolytic Agents; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Ticlopidine; Vitamin K | 2014 |
Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Humans; Male; Pilot Projects; Prospective Studies; Risk Assessment; Stroke; Vitamin K | 2014 |
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial.
Topics: Aged; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Risk Factors; Stroke; Treatment Outcome; Vitamin K | 2014 |
The use of a biologic topical haemostatic agent (TachoSil(®)) for the prevention of postoperative bleeding in patients on antithrombotic therapy undergoing thyroid surgery: A randomised controlled pilot trial.
Topics: Administration, Topical; Aged; Aspirin; Biological Products; Drug Combinations; Female; Fibrinogen; Fibrinolytic Agents; Hemostatics; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Pilot Projects; Postoperative Hemorrhage; Prospective Studies; Thrombin; Thyroid Gland; Thyroidectomy; Vitamin K | 2015 |
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 Enzyme System; Dabigatran; Double-Blind Method; Electrodes; Female; Humans; Light; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Thrombelastography; Thrombosis; Ticlopidine; Vitamin K | 2016 |
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Topics: Administration, Oral; Aged; Aspirin; Atrial Fibrillation; Disease-Free Survival; Double-Blind Method; Europe; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Rate; Humans; Incidence; Male; Prospective Studies; Pyridines; Risk Factors; Stroke; Survival Rate; Thiazoles; Time Factors; Treatment Outcome; Vitamin K | 2017 |
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Double-Blind Method; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Vitamin K | 2019 |
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sitagliptin Phosphate; Stroke; Time Factors; Treatment Outcome; Vitamin K | 2019 |
Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Agents; Combined Modality Therapy; Disease Management; Drug Therapy, Combination; Elective Surgical Procedures; Female; Fibrinolytic Agents; Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Treatment Outcome; Vitamin K | 2019 |
Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Artery Disease; Coronary Thrombosis; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Risk Factors; Stents; Time Factors; Treatment Outcome; Vitamin K | 2020 |
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial.
Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemia; Male; Medication Therapy Management; Middle Aged; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Preoperative Period; Pyrazoles; Pyridones; Vitamin K | 2022 |
124 other study(ies) available for aspirin and vitamin k semiquinone radical
| Article | Year |
|---|---|
The inhibition of the vitamin K-dependent carboxylation of glutamyl residues in prothrombin by some copper complexes.
Topics: Animals; Aspirin; Cattle; Copper; Erythrocytes; Kinetics; Male; Microsomes, Liver; Penicillamine; Prothrombin; Rats; Superoxide Dismutase; Tyrosine; Vitamin K; Vitamin K Deficiency | 1979 |
Selecting and preparing patients for total hip replacement.
Topics: Aged; Anticoagulants; Arthritis, Rheumatoid; Arthroplasty; Aspirin; Blood Coagulation; Blood Platelets; Dextrans; Follow-Up Studies; Heparin; Hip Joint; Humans; Joint Prosthesis; Osteoarthritis; Postoperative Complications; Spondylitis, Ankylosing; Vitamin K; Warfarin | 1977 |
[Comparative evaluation of aspirin and indirect-action anticoagulants in the prevention of venous thromboses in traumatology and orthopedic practice].
Topics: Adult; Anticoagulants; Aspirin; Drug Evaluation; Female; Fractures, Bone; Hemorrhage; Humans; Male; Middle Aged; Thromboembolism; Vitamin K | 1976 |
[Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
Topics: Adult; Anticoagulants; Aspirin; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Platelet Adhesiveness; Platelet Aggregation; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Thrombosis; Vitamin K | 1975 |
Bleeding, salicylates, and prolonged prothrombin time: three case reports and a review of the literature.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Epistaxis; Female; Humans; Hypoprothrombinemias; Malabsorption Syndromes; Male; Middle Aged; Nutrition Disorders; Vitamin K | 1976 |
[Role of antithrombotic agents after myocardial infarction].
Topics: Anticoagulants; Aspirin; Follow-Up Studies; Humans; Myocardial Infarction; Thrombolytic Therapy; Vitamin K | 1992 |
[Drug treatments of atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Recurrence; Vitamin K | 1992 |
[Prevention of thrombosis in orthopedic surgery].
Topics: Aspirin; Bandages; Combined Modality Therapy; Dextrans; Drug Therapy, Combination; Heparin; Humans; Orthopedics; Postoperative Complications; Thromboembolism; Vitamin K | 1991 |
Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation Factors; Blood Platelets; Chondroitin Sulfates; Coumarins; Dermatan Sulfate; Disease Models, Animal; Fibrin; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Immune Sera; Ligation; Male; Oligosaccharides; Rats; Thrombosis; Venae Cavae; Vitamin K | 1989 |
Effect of oral aspirin on plasma levels of vitamin K-dependent clotting factors--studies in healthy volunteers.
Topics: Administration, Oral; Adult; Aspirin; Blood Coagulation Factors; Double-Blind Method; Female; Humans; Male; Vitamin K | 1988 |
The role of fibrin in the inflammatory response to carrageenin.
Topics: Animals; Aspirin; Blood Coagulation; Carrageenan; Edema; Fibrin; Fibrinolysin; Heparin; Indenes; Male; Phenylbutazone; Prothrombin; Rats; Thrombin; Time Factors; Vitamin K | 1968 |
[Abdomino-digestive complications from anticoagulants].
Topics: Abdominal Muscles; Anticoagulants; Aspirin; Drug Synergism; Gastrointestinal Hemorrhage; Hematoma; Humans; Peritoneum; Vitamin K | 1973 |
[Digestive hemorrhages caused by drugs].
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Hemorrhage; Heparin; Humans; Vitamin K | 1973 |
[Compounds of some drugs with poly(vinylpyrrolidone)].
Topics: Aminopyrine; Aspirin; Drug Compounding; Nicotinic Acids; Povidone; Salicylates; Sulfathiazoles; Vitamin K | 1974 |
[Drug cytopenia with active antibodies in the presence of acetyl-salicylic acid and niflumic acid].
Topics: Adenine; Adult; Analgesics; Antibodies; Antigens; Aspirin; Blood Group Antigens; Blood Transfusion; Bone Marrow Examination; Dextropropoxyphene; Drug Hypersensitivity; Erythrocyte Count; Humans; Isoantibodies; Lectins; Leukocyte Count; Male; Melena; Nicotinic Acids; Rheumatic Diseases; Vitamin K | 1969 |
[Acetylsalicylic acid and blood platelets. A contribution to anticoagulation therapy].
Topics: Aspirin; Blood Coagulation; Blood Platelets; Humans; Vitamin K | 1969 |
Interactions between pharmaceutical compounds by thermal methods.
Topics: Acetaminophen; Aspirin; Atropine; Bile Acids and Salts; Caffeine; Drug Compounding; Drug Incompatibility; Drug Stability; Methods; Phenacetin; Phenobarbital; Phenytoin; Quinine; Temperature; Theophylline; Thermodynamics; Time Factors; Vitamin K | 1969 |
[Hemorrhagic complications of preventive anticoagulant therapy in surgery].
Topics: Anticoagulants; Aspirin; Dextrans; Dose-Response Relationship, Drug; Drug Interactions; Hemorrhage; Heparin; Humans; Preoperative Care; Risk; Thromboembolism; Vitamin K | 1983 |
[Antivitamin K, aspirin: treatments still of significance].
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Vitamin K | 1997 |
Aspirin poisoning during pregnancy: increased fetal sensitivity.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Gas Analysis; Blood Glucose; Diuresis; Female; Fetal Blood; Fetal Death; Fetus; Humans; Male; Pregnancy; Renal Dialysis; Vitamin K | 1998 |
[Vitamin K agonists in cerebral microembolism?].
Topics: Adult; Aged; Aspirin; Dose-Response Relationship, Drug; Female; Humans; Intracranial Embolism and Thrombosis; Risk Factors; Vitamin K | 1999 |
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Confidence Intervals; Dipyridamole; Drug Therapy, Combination; Embolectomy; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intermittent Claudication; Leg; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombectomy; Ticlopidine; Time Factors; Vitamin K | 2003 |
Influence on hemostasis, high blood pressure, antivitamin K, heparin and acetyl salicylic acid.
Topics: Aspirin; Blood Pressure; Fibrinolytic Agents; Hemostasis; Heparin; Humans; Vitamin K | 1955 |
Acetylsalicylic-acid toxicity and vitamin K.
Topics: Antifibrinolytic Agents; Aspirin; Heparin Antagonists; Humans; Naphthoquinones; Poisoning; Retinoids; Vitamin K | 1956 |
[Internal secretion].
Topics: Aspirin; Endocrine Glands; Muscle Relaxants, Central; Tranquilizing Agents; Tuberculosis; Vitamin A; Vitamin K; Vitamins | 1959 |
An evaluation of a buffered combination of acetylsalicylic acid, and vitamins C and K for collagen foot disorders.
Topics: Antifibrinolytic Agents; Ascorbic Acid; Aspirin; Collagen; Collagen Diseases; Foot Diseases; Hemostatics; Humans; Vitamin K; Vitamins | 1959 |
TREATMENT OF ACUTE RHEUMATIC FEVER.
Topics: Adolescent; Adrenal Cortex Hormones; Aspirin; Child; Cortisone; Dexamethasone; Ethylenediamines; Humans; Penicillin G; Penicillin G Benzathine; Prednisone; Rheumatic Fever; Vitamin K | 1963 |
SALICYLATE INTOXICATION IN CHILDREN--EXPERIENCE WITH PERITONEAL DIALYSIS AND ALKALINIZATION OF THE URINE.
Topics: Albumins; Aspirin; Bicarbonates; Blood; Blood Proteins; Calcium; Calcium, Dietary; Child; Chlorides; Dialysis; Hydrogen-Ion Concentration; Infant; Infusions, Parenteral; Osmosis; Peritoneal Dialysis; Potassium; Renal Dialysis; Salicylates; Sodium; Toxicology; Urine; Vitamin K | 1964 |
[THE EFFECT OF ASPIRIN ON THE VITAMIN K CONTENT OF THE BLOOD AND ITS CLINICAL USE].
Topics: Antifibrinolytic Agents; Aspirin; Blood; Drug Therapy; Heparin Antagonists; Humans; Naphthoquinones; Pharmacology; Prothrombin Time; Thrombosis; Vitamin K | 1964 |
Gastrointestinal hemorrhage from a large dose of acetylsalicylic acid.
Topics: Aspirin; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Hemorrhage; Humans; Vitamin K | 1951 |
Ximelagatran or warfarin in atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Drug Therapy, Combination; Humans; Prodrugs; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2004 |
Anticoagulation interruptus: not without risk.
Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Blood Loss, Surgical; Carotid Arteries; Dalteparin; Drug Administration Schedule; Elective Surgical Procedures; Filtration; Heart Valve Prosthesis Implantation; Humans; International Normalized Ratio; Intraoperative Care; Postoperative Care; Postoperative Complications; Postoperative Hemorrhage; Premedication; Stents; Thromboembolism; Thrombosis; Vitamin K; Warfarin | 2004 |
The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
Topics: Angioplasty; Animals; Arteries; Aspirin; Blood Coagulation Factors; Blood Platelets; Dose-Response Relationship, Drug; Fibrinogen; International Normalized Ratio; Platelet Adhesiveness; Swine; Thrombosis; Vitamin K; Warfarin | 2004 |
Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Clinical Trials as Topic; Female; Hemorrhage; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Pregnancy; Recurrence; Retrospective Studies; Risk; Vitamin K; Warfarin | 2005 |
Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Anticoagulants; Aspirin; Association; Blood Cell Count; Cerebral Hemorrhage; Clopidogrel; Databases, Factual; Drug Information Services; Germany; Hemorrhage; Heparin; Humans; Phenprocoumon; Platelet Aggregation Inhibitors; Product Surveillance, Postmarketing; Thrombocytopenia; Ticlopidine; Time Factors; Treatment Outcome; Vitamin K | 2005 |
[Peroral antithrombotic treatment].
Topics: Administration, Oral; Antifibrinolytic Agents; Aspirin; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Vitamin K | 2006 |
[Early non-obstructive thrombosis of mechanical mitral valve prostheses].
Topics: Adult; Aged; Anticoagulants; Aspirin; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Heparin; Humans; Male; Middle Aged; Mitral Valve; Retrospective Studies; Thrombosis; Treatment Outcome; Vitamin K | 2005 |
[Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment].
Topics: Administration, Oral; Age Factors; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Germany; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Registries; Risk Factors; Thromboembolism; Ticlopidine; Vitamin K | 2006 |
Low-molecular-weight heparin in pregnant women with prosthetic heart valves.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Biomarkers; Coronary Artery Disease; Drug Therapy, Combination; Embolism; Female; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Mitral Valve; Myocardial Infarction; Pregnancy; Pregnancy Complications, Cardiovascular; Quebec; Treatment Outcome; Vitamin K | 2006 |
[Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].
Topics: Aspirin; Cerebrovascular Disorders; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Recurrence; Treatment Outcome; Vitamin K | 2008 |
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Injections, Subcutaneous; Perioperative Care; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Ticlopidine; Treatment Outcome; Vitamin K | 2008 |
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Injections, Intravenous; Injections, Subcutaneous; International Normalized Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Vitamin K; Warfarin | 2008 |
Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Aspirin; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Diseases; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Vitamin K | 2008 |
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Antibodies, Antiphospholipid; Antithrombin III Deficiency; Aspirin; Evidence-Based Medicine; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Risk Assessment; Risk Factors; Thrombophilia; Venous Thromboembolism; Vitamin K | 2008 |
Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Topics: Aspirin; Child; Drug Therapy, Combination; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Partial Thromboplastin Time; Risk Assessment; Risk Factors; Venous Thrombosis; Vitamin K | 2008 |
[Anticoagulation in atrial fibrillation].
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Blood Coagulation; Blood Coagulation Factors; Dabigatran; Female; Humans; Middle Aged; Pyridines; Risk Factors; Stroke; Vitamin K | 2008 |
[Indications of vitamin K antagonists and aspirin in the atrial fibrillation of the elderly].
Topics: Aged; Aspirin; Atrial Fibrillation; Humans; Platelet Aggregation Inhibitors; Thromboembolism; Vitamin K | 2009 |
Effect of oral antiplatelet agents on major bleeding in users of coumarins.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Case-Control Studies; Clopidogrel; Coumarins; Dipyridamole; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Logistic Models; Male; Medical Records Systems, Computerized; Middle Aged; Netherlands; Odds Ratio; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Vitamin K | 2008 |
The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation.
Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K | 2009 |
Prevention of stroke in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vitamin K; Warfarin | 2009 |
Clopidogrel plus aspirin in atrial fibrillation.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K | 2009 |
Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
Topics: Aged; Aspirin; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation Inhibitors; Primary Prevention; Recurrence; Safety; Stroke; Survival Analysis; Vitamin K | 2009 |
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Vitamin K; Warfarin | 2009 |
The right oral antithrombotics in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prognosis; Ticlopidine; Vitamin K | 2009 |
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.
Topics: Adult; Aged; Aspirin; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Patient Admission; Proportional Hazards Models; Recurrence; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Vitamin K | 2009 |
How can we reduce disagreement among guidelines for venous thromboembolism prevention?
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Blood Loss, Surgical; Casts, Surgical; Evidence-Based Medicine; Fibrinolytic Agents; Guideline Adherence; Heparin; Hip Fractures; Humans; Knee; Lower Extremity; Orthopedic Procedures; Postoperative Hemorrhage; Practice Guidelines as Topic; Practice Patterns, Physicians'; Treatment Outcome; Venous Thromboembolism; Vitamin K | 2010 |
Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin therapy.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Enoxaparin; Female; Gelatin Sponge, Absorbable; Hemostatic Techniques; Hemostatics; Humans; Male; Middle Aged; Oral Hemorrhage; Oral Surgical Procedures; Plasma; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Sutures; Thrombin; Tooth Extraction; Venous Thrombosis; Vitamin K; Warfarin; Young Adult | 2010 |
Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Bioprosthesis; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Selection; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Thromboembolism; Time Factors; Treatment Outcome; Vitamin K; Warfarin | 2010 |
OCT follow-up of systemic lupus erythematosus choroidopathy.
Topics: 4-Hydroxycoumarins; Adolescent; Adrenal Cortex Hormones; Angiography; Antibodies, Antinuclear; Aspirin; Azathioprine; Choroid Diseases; Drug Monitoring; Female; Fluorescein; Humans; Immunosuppressive Agents; Indenes; Lupus Erythematosus, Systemic; Organic Chemicals; Retinal Detachment; Tomography, Optical Coherence; Vitamin K | 2010 |
Is early antithrombotic therapy necessary after tissue mitral valve replacement?
Topics: Aged; Aged, 80 and over; Animals; Anticoagulants; Aspirin; Bioprosthesis; Brain Ischemia; Cattle; Chi-Square Distribution; Drug Administration Schedule; Female; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Mitral Valve; Practice Guidelines as Topic; Prosthesis Design; Retrospective Studies; Risk Assessment; Risk Factors; Swine; Thrombosis; Time Factors; Treatment Outcome; Vitamin K | 2010 |
Invited commentary.
Topics: Acenocoumarol; Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Phenprocoumon; Vitamin K | 2010 |
Use of salicylates in rheumatic fever; mixture of aspirin and vitamin K unwarranted.
Topics: Antifibrinolytic Agents; Aspirin; Naphthoquinones; Retinoids; Rheumatic Fever; Salicylates; Vitamin K | 1945 |
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Female; Fibrinolytic Agents; Guideline Adherence; Humans; Internal Medicine; Intracranial Embolism; Italy; Male; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Stroke; Vitamin K | 2010 |
Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coated Materials, Biocompatible; Coronary Disease; Disease-Free Survival; Endothelial Cells; Female; Humans; Male; Platelet Aggregation Inhibitors; Stem Cells; Stents; Ticlopidine; Vitamin K | 2011 |
How do we manage patients treated with antithrombotic therapy in the perioperative interval.
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Aspirin; Blood Loss, Surgical; Blood Transfusion; Clopidogrel; Coagulants; Factor Xa Inhibitors; Fibrinolytic Agents; Hemostasis, Surgical; Heparin; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Risk Assessment; Ticlopidine; Vitamin K; Warfarin | 2011 |
[Intracerebral hemorrhage in anticoagulated patients: what do we do afterwards?].
Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Female; Follow-Up Studies; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Risk; Risk Factors; Stroke; Ticlopidine; Vitamin K | 2012 |
Pharmacological profile of Salvadora persica.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Behavior, Animal; Bleeding Time; Blood Coagulation; Diazepam; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ethanol; Hand Strength; Indomethacin; Mice; Pain Measurement; Plant Extracts; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Salvadoraceae; Tranexamic Acid; Vitamin K | 2011 |
Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cohort Studies; Denmark; Drug Evaluation; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Registries; Risk Assessment; Thromboembolism; Vitamin K | 2011 |
[Left main coronary artery aneurysm].
Topics: 4-Hydroxycoumarins; Anticoagulants; Aspirin; Coronary Aneurysm; Coronary Angiography; Coronary Vessels; Female; Follow-Up Studies; Humans; Indenes; Middle Aged; Vitamin K | 2011 |
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Drug Administration Schedule; Elective Surgical Procedures; Evidence-Based Medicine; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Societies, Medical; Stents; Thrombosis; United States; Vitamin K | 2012 |
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Evidence-Based Medicine; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Risk Factors; Societies, Medical; Stroke; Ticlopidine; Vitamin K | 2012 |
Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Aspirin; Catheterization; Combined Modality Therapy; Ductus Arteriosus, Patent; Evidence-Based Medicine; Fibrinolytic Agents; Heart Atria; Heart Valve Diseases; Heart Valve Prosthesis; Hemorrhage; Humans; Mitral Valve; Platelet Aggregation Inhibitors; Postoperative Complications; Rheumatic Heart Disease; Risk Factors; Societies, Medical; Stroke; Thromboembolism; Thrombolytic Therapy; Thrombosis; Vitamin K | 2012 |
Cross-sectional study of treatment strategies on atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Aspirin; Atrial Fibrillation; Brazil; Epidemiologic Methods; Female; Heart Conduction System; Heart Rate; Heart Valve Diseases; Humans; Male; Thromboembolism; Ventricular Dysfunction, Left; Vitamin K | 2012 |
Safety of withholding anticoagulation in patients with mechanical prosthetic valves and intracranial haemorrhage.
Topics: Adult; Anticoagulants; Aspirin; Atrial Fibrillation; Combined Modality Therapy; Comorbidity; Contraindications; Craniotomy; Female; Heart Valve Prosthesis; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Thailand; Thromboembolism; Time Factors; Vitamin K; Warfarin | 2011 |
Adherence to guidelines for the prescribing of double and triple combinations of antithrombotic agents.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Attitude of Health Personnel; Clopidogrel; Community Pharmacy Services; Comorbidity; Drug Interactions; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Female; Fibrinolytic Agents; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Hemorrhage; Humans; Male; Middle Aged; Netherlands; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Risk Assessment; Risk Factors; Surveys and Questionnaires; Ticlopidine; Vitamin K | 2014 |
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stroke; Ticlopidine; Vitamin K | 2012 |
[Bleeding tendency].
Topics: Antithrombins; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Hemorrhagic Disorders; Humans; Receptors, Cytoplasmic and Nuclear; Thrombocytopenia; Vitamin K | 2012 |
[Drugs news].
Topics: 4-Hydroxycoumarins; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Fibric Acids; France; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indenes; Meta-Analysis as Topic; Pancreatitis; Pharmacoepidemiology; Pharmacovigilance; Pneumonia; Randomized Controlled Trials as Topic; Treatment Outcome; Venous Thrombosis; Vitamin K | 2013 |
Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Patient Selection; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine; Vitamin K | 2013 |
Balancing thromboembolic risk against vitamin K antagonist-related bleeding and accelerated calcification: is fondaparinux the Holy Grail for end-stage renal disease patients with atrial fibrillation?
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Contraindications; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Humans; Kidney Failure, Chronic; Polysaccharides; Renal Dialysis; Thromboembolism; Vascular Calcification; Vitamin K; Warfarin | 2013 |
[From apixaban to aspirin in the prevention of recurrent venous thromboembolism].
Topics: Anticoagulants; Antithrombins; Aspirin; Clinical Trials as Topic; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Humans; Multicenter Studies as Topic; Pyrazoles; Pyridones; Recurrence; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamin K | 2013 |
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Vitamin K; Warfarin | 2014 |
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cost-Benefit Analysis; Drug Costs; Factor Xa Inhibitors; Female; Hemorrhage; Hospitalization; Humans; Male; Markov Chains; Middle Aged; Multicenter Studies as Topic; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin K; Warfarin | 2014 |
Triple antithrombotic therapy: risky but sometimes necessary.
Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticlopidine; Vitamin K | 2014 |
Anticoagulants as a risk factor in patients operated on for abdominal hernia.
Topics: Adult; Aged; Anticoagulants; Aspirin; Blood Coagulation Disorders; Drainage; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Hernia, Abdominal; Hospitalization; Humans; Male; Middle Aged; Perioperative Period; Poland; Postoperative Complications; Risk Factors; Vitamin K | 2014 |
Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yet.
Topics: Aspirin; Atrial Fibrillation; Humans; Percutaneous Coronary Intervention; Ticlopidine; Vitamin K | 2015 |
Reply: Triple therapy for atrial fibrillation and ACS with or without PCI: don't drop aspirin just yet.
Topics: Aspirin; Atrial Fibrillation; Humans; Percutaneous Coronary Intervention; Ticlopidine; Vitamin K | 2015 |
[Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
Topics: Acenocoumarol; Aged; Anticoagulants; Aspirin; Case-Control Studies; Causality; Comorbidity; Female; Humans; Hypercholesterolemia; Incidence; Macular Degeneration; Male; Population Surveillance; Prevalence; Risk Factors; Smoking; Vitamin K; Warfarin | 2015 |
Extracranial vertebral artery dissection in children: natural history and management.
Topics: Adolescent; Anticoagulants; Aspirin; Cerebral Angiography; Child; Child, Preschool; Female; Heparin, Low-Molecular-Weight; Humans; Infant; Magnetic Resonance Angiography; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Treatment Outcome; Vertebral Artery Dissection; Vitamin K | 2015 |
Antithrombotic drugs and subarachnoid haemorrhage risk. A nationwide case-control study in Denmark.
Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Risk; Subarachnoid Hemorrhage; Thrombosis; Ticlopidine; Vitamin K | 2015 |
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Registries; Stroke; Treatment Outcome; Vitamin K | 2015 |
Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Female; Hospital Mortality; Humans; International Normalized Ratio; Male; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke; Vitamin K | 2016 |
Prevention of deep vein thrombosis. First choice treatments.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Early Ambulation; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Stockings, Compression; Thrombocytopenia; Venous Thrombosis; Vitamin K; Warfarin | 2015 |
Hemoptysis due to aspirin treatment alternative to warfarin therapy in a patient with atrial fibrillation.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Drug Interactions; Female; Hemoptysis; Humans; International Normalized Ratio; Tooth Extraction; Vitamin K; Warfarin | 2015 |
The long-term fate of epistaxis patients with exposure to antithrombotic medication.
Topics: Adult; Aspirin; Cohort Studies; Epistaxis; Female; Fibrinolytic Agents; Humans; Long Term Adverse Effects; Male; Middle Aged; Nasal Surgical Procedures; Prognosis; Retrospective Studies; Risk Factors; Secondary Prevention; Severity of Illness Index; Switzerland; Vitamin K | 2016 |
Does the choice of thrombotic prophylactic drug depend on the known risk factors of patients with multiple myeloma in clinical practice?
Topics: Aged; Angiogenesis Inhibitors; Anticoagulants; Aspirin; Female; Heparin, Low-Molecular-Weight; Humans; Lenalidomide; Male; Multiple Myeloma; Risk Factors; Thalidomide; Thrombosis; Vitamin K | 2016 |
Locked Away: Percutaneous Closure of a Malignant Left Atrial Appendage to Constrain an Unresolvable Thrombus.
Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Echocardiography, Transesophageal; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Septal Occluder Device; Thrombosis; Ticlopidine; Vitamin K | 2016 |
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
Topics: Administration, Oral; Anticoagulants; Aspirin; Dabigatran; Humans; Italy; Pyrazoles; Pyridones; Rivaroxaban; Time Factors; Venous Thromboembolism; Vitamin K; Warfarin | 2016 |
Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis.
Topics: Acute Coronary Syndrome; Administration, Oral; Animals; Anticoagulants; Arteries; Aspirin; Atherosclerosis; Binding Sites; Blood Platelets; Fibrinolytic Agents; Humans; Mice; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Thrombin; Thrombosis; Vitamin K | 2016 |
Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; Vitamin K; Young Adult | 2017 |
Association of Antithrombotic Drug Use With Subdural Hematoma Risk.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Comorbidity; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hematoma, Subdural; Humans; Incidence; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Vitamin K; Young Adult | 2017 |
Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants.
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Vitamin K | 2017 |
A comparison between vitamin K antagonists and new oral anticoagulants.
Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Vitamin K; Warfarin | 2017 |
[Evaluation of the antithrombotic strategy in low thrombotic risk patients who underwent aortic valve replacement with a bioprosthesis].
Topics: Adult; Aged; Anticoagulants; Aortic Valve; Aspirin; Bioprosthesis; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Mexico; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Vitamin K | 2018 |
Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studies.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Humans; Myocardial Infarction; Vitamin K | 2017 |
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome; Vitamin K | 2018 |
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Guideline Adherence; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Stents; Stroke; Thrombosis; Vitamin K | 2018 |
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.
Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K | 2018 |
Antithrombotic therapy after mitral valve repair: VKA or aspirin?
Topics: Aged; Aspirin; Cardiac Surgical Procedures; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Mitral Valve Annuloplasty; Retrospective Studies; Thromboembolism; Vitamin K | 2018 |
Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves.
Topics: Aged; Anticoagulants; Aspirin; Bioprosthesis; Clopidogrel; Drug Therapy, Combination; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Vitamin K; Warfarin | 2018 |
Stroke prevention in patients with acute ischemic stroke and atrial fibrillation in Germany - a cross sectional survey.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cross-Sectional Studies; Female; Germany; Humans; Male; Middle Aged; Recurrence; Risk Factors; Secondary Prevention; Stroke; Vitamin K | 2019 |
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Agents; Combined Modality Therapy; Drug Therapy, Combination; Elective Surgical Procedures; Female; Fibrinolytic Agents; Hemorrhage; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vitamin K | 2019 |
Mortality risk in atrial fibrillation: the role of aspirin, vitamin K and non-vitamin K antagonists.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cohort Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Sex Factors; Stroke; Vitamin K | 2019 |
Warfarin Reinitiation After Intracranial Hemorrhage: A Case Series of Heart Valve Patients.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Aortic Valve; Aspirin; Blood Coagulation Factors; Cerebral Hemorrhage; Female; Heart Valve Prosthesis; Hematoma, Subdural; Humans; International Normalized Ratio; Intracranial Hemorrhages; Male; Middle Aged; Mitral Valve; Plasma; Platelet Aggregation Inhibitors; Pregnancy; Retrospective Studies; Subarachnoid Hemorrhage; Subarachnoid Hemorrhage, Traumatic; Thromboembolism; Vitamin K; Warfarin | 2020 |
Management of blunt hepatic and splenic injuries (grade ≤ III) in patients receiving antithrombotic therapy.
Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Aspirin; Blood Coagulation Factors; Blood Transfusion; Combined Modality Therapy; Critical Care; Disease Management; Feasibility Studies; Female; Fibrinolytic Agents; Hemorrhage; Humans; Injury Severity Score; Length of Stay; Liver; Male; Middle Aged; Plasma; Prospective Studies; Spleen; Treatment Outcome; Vitamin K; Wounds, Nonpenetrating | 2019 |
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Coronary Thrombosis; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Ischemia; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamin K | 2020 |
Beyond current concepts in anti-phospholipid syndrome: The 16th International Congress on Anti-phospholipid Antibodies (ICAPA) in Manchester.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Heparin; Humans; Pregnancy; Pregnancy Complications; Vitamin K | 2020 |
[Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation].
Topics: Acute Coronary Syndrome; Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Combined Modality Therapy; Cyclophosphamide; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stents; Stroke; Vitamin K | 2020 |
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atrial Fibrillation; Factor Xa Inhibitors; Female; Humans; Kidney; Male; Middle Aged; Percutaneous Coronary Intervention; Pyrazoles; Pyridones; Vitamin K | 2021 |
The impact of antiplatelet and antithrombotic regimen after TAVI: Data from the VIenna CardioThOracic Aortic Valve RegistrY (VICTORY).
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Valve Stenosis; Aspirin; Austria; Clopidogrel; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Postoperative Care; Registries; Survival Rate; Transcatheter Aortic Valve Replacement; Vitamin K | 2021 |
Treatment of Catheter-Related Arterial Thrombosis in Children: A 15-Year Single- Center Experience.
Topics: Adolescent; Anticoagulants; Aspirin; Cardiac Catheterization; Catheters, Indwelling; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Femoral Artery; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Iliac Artery; Infant; Infant, Newborn; Male; Retrospective Studies; Thrombosis; Treatment Outcome; Vitamin K | 2021 |
Long-term outcomes after traumatic brain injury in elderly patients on antithrombotic therapy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Brain Injuries, Traumatic; Fibrinolytic Agents; Hematoma, Subdural; Humans; Retrospective Studies; Vitamin K | 2023 |